Affinity Therapeutics, LLC

Cleveland, OH 44106

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $1.18MM
First Award Date 04/01/12
Most Recent Award Date 04/01/17

Key Personnel

Last Name Name Awards Contact
Korley Julius Korley 4 Message
ZUCKERMAN SEAN T. ZUCKERMAN 4

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 04/01/17 - 03/31/18

Abstract Summary Arteriovenous fistulas (AVFs) are the preferred vascular access mode for hemodialysis patients, but ~60% of AVFs fail to mature and only ~60% of mature AVFs are patent after 1 year. Vascular access failure, including AVFs, results from neointimal hyperplasia and contributes to >$1 billion USD annual costs from vascular access fa...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 04/01/15 - 03/31/16

DESCRIPTION (provided by applicant): There are greater than 1.6 million patients that suffer end stage renal disease requiring hemodialysis. Long term vascular access is vital for these patients to undergo hemodialysis and is obtained via surgical construction of an arteriovenous (AV) fistula or interposition of an AV graft. Failure of vascular ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 09/15/14 - 12/31/14

DESCRIPTION (provided by applicant): There are greater than 1.6 million patients that suffer end stage renal disease requiring hemodialysis. Long term vascular access is vital for these patients to undergo hemodialysis and is obtained via surgical construction of an arteriovenous (AV) fistula or interposition of an AV graft. Failure of vascular ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 04/15/14 - 03/31/15

Abstract Summary There are greater than 1.6 million patients that suffer end stage renal disease requiring hemodialysis. Long term vascular access is vital for these patients to undergo hemodialysis and is obtained via surgical construction of an arteriovenous (AV) fistula or interposition of an AV graft. Failure of vascular access results in st...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 04/01/13 - 03/31/14

DESCRIPTION (provided by applicant): One of the leading causes of failure for medical devices is infection. In particular synthetic mesh infections after ventral hernia repair are a common surgical problem with no ideal solution often requiring implant excision through costly morbid interventions. Options to prevent short and long term mesh infe...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BC-2012
Budget: 01/01/13 - 12/31/13

This Small Business Innovation Research (SBIR) Phase I project concerns a major health concern both here in the US and abroad. Currently, no long-term vaginal delivery device is available for the delivery of proteins such as are being investigated for HIV prevention. Our long-term goal is to prevent person-to-person HIV transmission through the ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 04/01/12 - 03/31/13

DESCRIPTION (provided by applicant): One of the leading causes of failure for medical devices is infection. In particular synthetic mesh infections after ventral hernia repair are a common surgical problem with no ideal solution often requiring implant excision through costly morbid interventions. Options to prevent short and long term mesh infe...